Discontinued — last reported Q4 '17

Non-Current Assets

Indefinite-Lived Research and Development Assets

International Business Machines Indefinite-Lived Research and Development Assets increased by 5.8% to $4.43B in Q4 2025 compared to the prior quarter. Over 3 years (FY 2022 to FY 2025), Indefinite-Lived Research and Development Assets shows an upward trend with a 13.7% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ3 2015
Last reportedQ4 2017

How to read this metric

An increase indicates active investment in future technology, while a decrease may signal project completion or impairment.

Detailed definition

These are acquired in-process research and development (IPR&D) projects that have not yet reached technological feasibil...

Peer comparison

Common in technology and pharmaceutical sectors following M&A activity.

Metric ID: indefinite_lived_rd_assets

Historical Data

4 periods
 Q4 '22Q4 '23Q4 '24Q4 '25
Value$3.01B$3.52B$4.19B$4.43B
QoQ Change—+17.0%+18.8%+5.8%
YoY Change—+17.0%+18.8%+5.8%
Range$3.01B – $4.43B
Avg YoY Growth+13.8%
Median YoY Growth+17.0%
Current Streak3+ quarters growth

Frequently Asked Questions

What is International Business Machines's indefinite-lived research and development assets?
International Business Machines (IBM) reported indefinite-lived research and development assets of $4.43B in Q4 2025.
What is the long-term trend for International Business Machines's indefinite-lived research and development assets?
Over 3 years (2022 to 2025), International Business Machines's indefinite-lived research and development assets has grown at a 13.7% compound annual growth rate (CAGR), from $3.01B to $4.43B.
What does indefinite-lived research and development assets mean?
The value of research projects acquired from other companies that are still in progress.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.